shot-button
E-paper E-paper
Home > Lifestyle News > Health And Fitness News > Article > Steroid creams used to treat inflammatory skin conditions may affect bone health Study

Steroid creams used to treat inflammatory skin conditions may affect bone health: Study

Updated on: 22 December,2023 08:31 AM IST  |  Taipei
IANS |

Topical corticosteroids to treat inflammatory skin conditions should be done very carefully and clinicians should be aware of these potential side effects

Steroid creams used to treat inflammatory skin conditions may affect bone health: Study

Image for representational purposes only. Photo Courtesy: iStock

Higher doses of topical corticosteroids, which are commonly used to treat inflammatory skin conditions, can elevate risks of osteoporosis and bone fractures associated with osteoporosis, indicates a new research.


Systemic corticosteroids are known to interfere with bone remodelling and increase osteoporosis and fracture risk, but evidence on the topical corticosteroids on bone health has been inconclusive.


The study, published in the Journal of the European Academy of Dermatology and Venereology, showed that clear link, particularly for extended periods of exposure. Young people and women were found to have an increased risk, the study said.


“This study emphasises that using topical corticosteroids to treat inflammatory skin conditions should be done very carefully and clinicians should be aware of these potential side effects,” said corresponding author Chia-Yu Chu, of National Taiwan University Hospital and National Taiwan University College of Medicine.

For the study, the team selected 129,682 osteoporosis cases and 34,999 major osteoporotic fracture (MOF) cases and matched them with 518,728 and 139,996 controls (without osteoporosis or MOF) by sex and age.

The results showed clear dose-response relationships between long-term use of topical corticosteroids and osteoporosis and MOF.

For example, compared with no doses, low, medium, and high cumulative doses of topical corticosteroids were associated with 1.22-, 1.26-, and 1.34-times higher odds of developing osteoporosis over five years.

These respective doses were linked with 1.12-, 1.19-, and 1.29-times higher odds of experiencing MOF. Women had higher risks of osteoporosis and MOF than men. Also, younger people (below 50 years) had a higher risk of osteoporosis compared with other age groups.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK